跳至主要内容
临床试验/NCT03388450
NCT03388450已完成不适用

Effect of Enteral Nutrition With Omega-3 Fatty Acid in Critically Ill Septic Patients.

Menoufia University0 个研究点目标入组 110 人开始时间: 2015年1月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
110
主要终点
Organs dysfunction free days.

研究概览

简要总结

Sepsis is the most common reason for intensive care unit (ICU) admission. Sepsis flares up the systemic inflammatory response with its mediators. Sepsis treatment protocols have been established in many centres with immune nutrient as adjuvant treatment. Omega-3 fatty acid and other anti-oxidants formulae have been found to improve sepsis outcome. In most of the studies, immune nutrients were giving parenterally, however, nowadays the preferable route of feeding in critically ill patients is enterally. The present study was done to investigate the effect of enteral Omega-3 fatty acid in septic critically ill patients.

详细描述

A hundred and ten critically ill septic patients were included in the study. Patients were divided into two groups fifty-five patients each. Group A received enteral nutrition supplemented with Omega-3 fatty acid and group B received enteral nutrition without Omega-3. Demographic data, sepsis characteristics, number of patients required invasive ventilation, ventilation days, ICU sequential organ failure assessment score (SOFA), organ failure free-days, haemodynamic failure free-days, ICU stay, ICU and hospital outcomes were recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All septic patients who could receive enteral nutrition were included in the study

排除标准

  • Patients with end stage liver or renal disease, haemodynamic instability, immunosuppression, gastrointestinal comorbidity, allergic to omega-3, received omega-3 a week prior to ICU admission, patients who expected to live less than 24 hours, and patients who were mechanically ventilated on ICU admission were excluded from the study.

研究组 & 干预措施

Placebo

Placebo Comparator

Patients received enteral nutrition supplemented without 1000 mg omega-3.

干预措施: Placebo (Drug)

Omega 3

Active Comparator

Patients received enteral nutrition supplemented with 1000 mg omega-3.

干预措施: Omega 3 (Drug)

结局指标

主要结局

Organs dysfunction free days.

时间窗: 25 days during ICU stay.

The number of organs dysfunction free days (haemodynamic failure and respiratory failure free days).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Ezzeldin Ibrahim

Assistant Professor in anaesthesia, intensive care, and pain medicine.

Menoufia University

相似试验

Omega-3 Fatty Acid for Critically Ill Patients. | 临床试验